Wednesday, June 29, 2016

In today's long line-up of research reports, we want to highlight Amgen (AMGN), Kraft Heinz (KHC), and UPS (UPS)

Amgen shares have been weak lately given the overall tough environment for the space, but this Zack Rank # 2 (Buy) biotech major  is well-positioned for growth with several blockbuster drugs in its portfolio. (Full research report on AMGN)

Kraft Heinz share have benefited from business consolidation and cost saving measures that are helping its margins. The analyst likes this buy-rated stock's impressive portfolio of packaged food and beverage products. (Full research report on KHC)

There is a reason why UPS shares have outperformed t FedEx (FDX), which you can see in the research report on UPS .

Other reports today include Barclays (BCS), Gilead (GILD) and Expedia (EXPE).

• Barclays (BCS) Becoming Brexit Victim
•  Gilead (GILD) Wins FDA Nod
•  Brexit May Not Hurt Expedia (EXPE)

You can find all of today's stock research reports here.

Note: Sheraz Mian regularly provides earnings analysis on Zacks.com and appears frequently in the print and electronic media. He also provides weekly commentary to Zacks Premium subscribers and manages the Zacks Focus List and Top 10 portfolios. If you want an email notification each time Sheraz publishes a new article, please click here